IP Library Granted Patent US 9,861,309
Granted Patent B2
US 9,861,309 · App. 14/566,952 · Granted Jan 9, 2018

Glucose monitoring system as control input to adjustable focal length lenses

Inventor: Linda M. Bal (Austin, TX)
Assignee: NXP USA, Inc.
A61B5/4836A61B5/14532A61B5/7275G02C7/04G02C7/083A61B5/082A61B5/14503A61B5/14517A61B5/7282
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,861,309
App. No.
14/566,952
Granted
Jan 9, 2018
Kind
B2
Abstract

A mechanism to adjust variable focus lenses using monitored glucose levels is provided. A glucose sensor provides current blood glucose levels to a controller for the variable focus lenses. The controller determines appropriate adjustment control information for the variable focus lenses based upon the reported glucose levels. This adjustment control information is provided to the lenses, which are adjusted accordingly.

Claims (24)

1. A system for adjusting a variable focal length lens in response to blood glucose level, the system comprising:

a glucose sensor system, configured to continuously provide blood glucose information, and comprising

an analyte sensor configured to detect blood glucose levels and provide information regarding the detected blood glucose levels, and

a transmitter configured to receive the information regarding the detected blood glucose levels from the analyte sensor and to transmit corresponding blood glucose information to a glucose level converter;

the glucose level converter, coupled to the glucose sensor system and a controller for the variable focal length lens, and configured to

determine a blood glucose level associated with the blood glucose information received from the glucose sensor system,

determine a current focal length using the blood glucose level where determining the current focal length comprises using the blood glucose level and a predetermined function derived from a set of measurements of optical prescription in light of blood glucose level for a user of the system,

determine the current set of control information for the variable focal length lens using the current focal length, and

provide the current set of control information to the controller.

2. The system of claim 1 wherein the analyte sensor comprises one of a transcutaneous analyte sensor, a sensor configured to detect glucose levels in tears, a sensor configured to detect acetone levels in breath, or a sensor configured to detect glucose levels in sweat.

3. The system of claim 1 wherein the glucose level converter is configured to determine the current set of control information for the variable focal length lens by being further configured to

determine a difference between the current focal length and an immediately previously set focal length;

determine the current set of control information for the variable focal length lens using the current focal length, if a magnitude of the difference between the current focal length and the immediately previously set focal length is greater than a predetermined threshold.

4. The system of claim 1 further comprising:

the variable focal length lens, wherein the variable focal length lens is coupled to the controller for the variable focal length lens.

5. A method for adjusting a variable focal length lens in response to blood glucose levels, the method comprising:

measuring a current blood glucose level said measuring comprising detecting the blood glucose level using an analyte sensor and continuously transmitting blood glucose information corresponding to the detected blood glucose level to a glucose level converter;

determining if the current blood glucose level requires a change in focal length of the variable focal length lens, comprising

determining a blood glucose level associated with the blood glucose information, and

determining a current focal length using the blood glucose level using a predetermined function derived from a set of measurements of optical prescription in light of blood glucose level for a user of the system;

determining a current set of control information for the variable focal length lens, if the current blood glucose level requires a change in focal length, and adjusting the variable focal length lens based on the set of control information.

6. The method of claim 5 wherein determining the set of control information further comprises:

determining a difference between the current focal length and an immediately previously set focal length;

determining the current set of control information for the variable focal length lens using the current focal length, if a magnitude of the difference between the current focal length and the immediately previously set focal length is greater than a predetermined threshold.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Sep 10, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: NXP B.V.
Reel/Frame 050744/0097 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED AT REEL: 040626 FRAME: 0683. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME EFFECTIVE NOVEMBER 7, 2016. Recorded Jan 12, 2017
From: NXP SEMICONDUCTORS USA, INC. (MERGED INTO); FREESCALE SEMICONDUCTOR, INC. (UNDER)
To: NXP USA, INC.
Reel/Frame 041414/0883 →
CHANGE OF NAME Recorded Nov 16, 2016
From: FREESCALE SEMICONDUCTOR INC.
To: NXP USA, INC.
Reel/Frame 040626/0683 →
SUPPLEMENT TO THE SECURITY AGREEMENT Recorded Jun 16, 2016
From: FREESCALE SEMICONDUCTOR, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 039138/0001 →
ASSIGNMENT AND ASSUMPTION OF SECURITY INTEREST IN PATENTS Recorded Jan 5, 2016
From: CITIBANK, N.A.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 037444/0444 →
ASSIGNMENT AND ASSUMPTION OF SECURITY INTEREST IN PATENTS Recorded Jan 5, 2016
From: CITIBANK, N.A.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 037444/0535 →
PATENT RELEASE Recorded Dec 21, 2015
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: FREESCALE SEMICONDUCTOR, INC.
Reel/Frame 037358/0001 →
SUPPLEMENT TO IP SECURITY AGREEMENT Recorded Feb 18, 2015
From: FREESCALE SEMICONDUCTOR, INC.
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 035034/0019 →
SUPPLEMENT TO IP SECURITY AGREEMENT Recorded Feb 18, 2015
From: FREESCALE SEMICONDUCTOR, INC.
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 035033/0923 →
SUPPLEMENT TO IP SECURITY AGREEMENT Recorded Feb 18, 2015
From: FREESCALE SEMICONDUCTOR, INC.
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 035033/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2014
From: BAL, LINDA M.
To: FREESCALE SEMICONDUCTOR, INC.
Reel/Frame 034480/0764 →
Continuity (1)
Related Publication 20160166200A1 · Jun 16, 2016